InvestorsHub Logo
Followers 19
Posts 817
Boards Moderated 0
Alias Born 12/12/2016

Re: Talon38 post# 213133

Saturday, 10/05/2019 8:56:32 AM

Saturday, October 05, 2019 8:56:32 AM

Post# of 462976
Agreed and in light of our being one of the last oral presentations and the late breaking presentations at the AAIC and CTAD in the past couple of years, and with the BIO panels and bold presentations such as yesterday’s, you’re right Merck and other BP are aware.

Rightly many have been concerned for a few years I’m sure.

Anavex has basically put the scientific/investing world on notice that our compounds, and 2-73 in particular, SEEM to be illustrating (through results and publications) that they may very well be efficacious for AD, Epilepsy, PDD, RSD, MS?, FTD, autism, among other benefits/indications.

AND that they can illustrate how/why, correlated to established biomarkers (something the FDA has encouraged, on paper at least, for new PM initiatives).

And that we aren’t interested in or pursuing BP’s failed symptoms-based approach, but rather we are targeting/solving the root causes of these diseases.

To think that the BP masters of the universe, and those in control of the system, haven’t heard about us at this point would be unfathomable.

Their goal is to marginalize, block & tackle, use online agents to create uncertainty and doubt. And likely lobby/influence Washington & regulators behind the scenes to slow down threats from small promising companies such as ours.

Dr M appears to be steps ahead of those tactics now however.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News